Mark Doherty, M.D.
NPI 1801892260 · Dermatology Physician · Bellingham, WA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1801892260
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- MD00020973 (WA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
5,056 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 2,594 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 679 | $94 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 524 | $59 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 | 227 | $175 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 164 | $59 |
| Biopsy of Related Skin Growth, First Growth11102 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 155 | 68 |
| Triamcinolone Acetonide | 81 | 60 |
| Fluorouracil | 27 | 25 |
| Lidocaine Hclbrand: Lidocaine Hcl Viscous | 15 | — |
| Terbinafine Hcl | 13 | — |
| Valacyclovir Hclbrand: Valacyclovir | 12 | — |
| Metronidazole | 12 | — |
| Ciclopirox Olamine |
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-06-21
- Last updated
- 2024-10-17
- Certified
- 2024-10-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.